NCT Number: NCT00333021
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients
This study is phase 3 study for prevention of VTE in patients with abdominal surgery.
Looking for future studies?
Notify MeKey information
Conditions
Age range
40 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
GSK Investigational Site, Hiroshima, Japan
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients aged >=40 years undergoing the following abdominal (diaphragm to pelvic floor) surgery under general anesthesia lasting more than 45 minutes.
- General or urologic surgery
- Cancer surgery
- Gynecologic surgery
- Radical surgery for pelvic malignancy
Exclusion criteria
- Active, clinically significant bleeding Thrombocytopenia Body weight <40kg
Treatment and study plan
GSK576428
DrugOther names: Fondaparinux sodium
Primary outcomes
-
Incidence of Venous thromboembolism and Major bleeding
Time frame: Throughout entire study
Secondary outcomes
-
Incidence of Pulmonary embolism Incidence of Deep vein thrombosis Incidence of symptomatic Venous thromboembolism
Time frame: Throughout entire study
Sponsors and collaborators
Lead sponsor
GlaxoSmithKline
Industry
Registry information
Official study title
Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery
Important dates
- Study start
- 2006
- Study completion
- 2007
- First posted
- Jun 2, 2006
- Registry last updated
- Jul 10, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Impact of COVID-19 Vaccines on Cerebrovascular Health
NCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsReplication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
NCT04736420
Cardiovascular Diseases, Embolism and Thrombosis
Boston, Massachusetts, United States
View Trial DetailsThe Protrieve PROTECTOR Study
NCT06495996
Cardiovascular Diseases, Deep Venous Thrombosis
Newport Beach, California, United States
View Trial DetailsTiming of Thromboprophylaxis After Postpartum Hemorrhage
NCT07689136
Cardiovascular Diseases, Deep Vein Thrombosis
Tunis, Tunisia
View Trial Details